The FDA has accepted the biologics licensing application (BLA) resubmission for odronextamab, a potential treatment for ...

At what was supposed to be a hearing to discuss PBM reform, some in Congress veered off into discussions about Medicaid and ...

Janssen has sued Samsung Bioepis, alleging it violated a settlement agreement by authorizing an unauthorized Stelara® ...

Johnson & Johnson is suing Samsung Bioepis for allegedly breaching the terms of a contract regarding the launch of the Korean ...

MedImpact Healthcare Systems, the nation’s largest independent provider of health solutions, technology, and pharmacy benefit ...